drugset / Trial / NCT05035953
Thrombolysis Combined With Edaravone Dexborneol on Hemorrhagic Transformation for Acute Ischemic Stroke
RandomizedParallel-groupDouble-blindTreatment
Summary
To explore the safety and efficacy of edaravone dexborneol for the treatment of acute ischemic stroke patients who received thrombolysis.
Timeline
- Start
- 2021-09-13
- Primary completion
- 2023-09-13
- Completion
- 2024-03-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexborneol | Small molecule | 7.5 mg | — |
| Subject | Edaravone | Unknown | 30 mg | — |